Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Keiji Yoshioka"'
Autor:
Haruyo Akiyama, Chisato Kurisaka, Dai Muramatsu, Shuhei Takada, Kei Toyama, Keiji Yoshioka, Ryosuke Nakamura
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss 1 (2024)
Diclofenac etalhyaluronate, an active pharmaceutical ingredient in JOYCLU® (JCL), serves as a joint function improvement agent in knee and hip osteoarthritis patients. However, frequent cases of anaphylaxis induced by JCL administration have been re
Externí odkaz:
https://doaj.org/article/8ddf47666a304429af2f20c2454755be
Publikováno v:
International Journal of Infectious Diseases, Vol 116, Iss , Pp 238-240 (2022)
Coronavirus disease 2019 (COVID-19) and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are associated with cardiovascular complications. Here, we report a case of right-sided heart failure caused by constrictive peri
Externí odkaz:
https://doaj.org/article/faa4daceb3f04a8189d2226c82b75e55
Autor:
Keiji Yoshioka, Madoka Katayama, Takeo Nishiyama, Kohei Harada, Sawako Takeshita, Yuji Kawamata
Publikováno v:
BMC Musculoskeletal Disorders, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Intra-articular (IA) injection of hyaluronic acid (HA) (IA-HA) is a well-recognized treatment option for pain associated with symptomatic knee osteoarthritis (OA). IA-HA products differ in their HA content, molecular weight, cross
Externí odkaz:
https://doaj.org/article/99084f0ca2094e389717558b7a5efa62
Publikováno v:
BMC Musculoskeletal Disorders, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background We have reported that a single intra-articular injection of diclofenac etalhyaluronate (SI-613) exerted a potent and long-lasting analgesic effect in experimental arthritis models. In the present study, we investigated the effect
Externí odkaz:
https://doaj.org/article/d248b43bfea14817866a5bbf605f7bfa
Publikováno v:
BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-12 (2018)
Abstract Background Osteoarthritis (OA) is the most common joint disorder worldwide and one of the leading causes of disability in the elderly. We have investigated the novel sodium hyaluronate derivative chemically linked with diclofenac (DF), diclo
Externí odkaz:
https://doaj.org/article/5a5a6c4e90614995930de3fce40c9d82
Autor:
Katsuya Takahashi, Hirotaka Hoshi, Hiroyuki Matsushima, Kiyoshi Suzuki, Keiji Yoshioka, Ippei Watanabe, Mayumi Nagata
Publikováno v:
Chemical and Pharmaceutical Bulletin. 69:595-599
Retention durability, especially in the eye, is one of the most important properties of ophthalmic viscosurgical devices (OVDs) during ocular surgery. However, the information on the physical properties of OVDs is insufficient to explain their retent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::391e5adb9064f8bff74b11d1741c6b2c
https://doi.org/10.1248/cpb.c21-00116
https://doi.org/10.1248/cpb.c21-00116
Publikováno v:
YAKUGAKU ZASSHI. 140:1141-1150
Osteoarthritis is the most common joint disorder worldwide and one of the leading causes of disability in the elderly. We have reported that the novel sodium hyaluronate derivative chemically linked with diclofenac (DF), diclofenac etalhyaluronate (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75287861e123f1087d13c8473b804567
https://doi.org/10.1248/yakushi.20-00008
https://doi.org/10.1248/yakushi.20-00008
Publikováno v:
BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-12 (2018)
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders
Background Osteoarthritis (OA) is the most common joint disorder worldwide and one of the leading causes of disability in the elderly. We have investigated the novel sodium hyaluronate derivative chemically linked with diclofenac (DF), diclofenac eta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdb6577f68184dfa19a3a65b020f6ce8
http://link.springer.com/article/10.1186/s12891-018-2077-8
http://link.springer.com/article/10.1186/s12891-018-2077-8
Autor:
Kohei Harada, Takeo Nishiyama, Yuji Kawamata, Sawako Takeshita, Madoka Katayama, Keiji Yoshioka
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 20, Iss 1, Pp 1-9 (2019)
BMC Musculoskeletal Disorders, Vol 20, Iss 1, Pp 1-9 (2019)
Background Intra-articular (IA) injection of hyaluronic acid (HA) (IA-HA) is a well-recognized treatment option for pain associated with symptomatic knee osteoarthritis (OA). IA-HA products differ in their HA content, molecular weight, cross-linking,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1488d9695cb3af89755646598c3808
http://europepmc.org/articles/PMC6739973
http://europepmc.org/articles/PMC6739973
Publikováno v:
BMC Musculoskeletal Disorders, Vol 20, Iss 1, Pp 1-9 (2019)
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders
Background We have reported that a single intra-articular injection of diclofenac etalhyaluronate (SI-613) exerted a potent and long-lasting analgesic effect in experimental arthritis models. In the present study, we investigated the effect of SI-613
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22797d6740cd209c260debb5ec958d98
https://doi.org/10.1186/s12891-019-2586-0
https://doi.org/10.1186/s12891-019-2586-0